Invention Grant
- Patent Title: Tricyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
-
Application No.: US15317546Application Date: 2015-06-05
-
Publication No.: US09708323B2Publication Date: 2017-07-18
- Inventor: Ivar M. McDonald , F. Christopher Zusi , Richard E. Olson
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent James Epperson
- International Application: PCT/US2015/034569 WO 20150605
- International Announcement: WO2015/191403 WO 20151217
- Main IPC: C07D471/18
- IPC: C07D471/18
Abstract:
The disclosure provides compounds of formula I including their salts, as well as compositions and methods of using the compounds. The compounds are ligands for the nicotinic 7 receptor and may be useful for the treatment of various disorders of the central nervous system, especially affective and neurodegenerative disorders.
Public/Granted literature
- US20170137425A1 TRICYCLIC COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS Public/Granted day:2017-05-18
Information query
